Mubadala Ventures is the venture capital arm of Mubadala that focuses on advanced technology.
Mubadala Capital’s Ventures business builds on Mubadala’s 10-year track record of being an active investor in advanced technology. The Ventures platform includes a direct investment business, a fund of funds business and the management and oversight of Mubadala’s partnership with SoftBank, including its U.S. $15 billion LP commitment to the SoftBank Vision Fund. The Ventures team is based in Abu Dhabi, San Francisco, and London with strong connectivity to European and Chinese venture capital markets through other Mubadala Capital managed vehicles.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 9, 2022
Ramp
|
Series B | $70M | Blockchain | Yes |
Oct 11, 2022
Neumora Therapeutics
|
Series B | $112M | Biotechnology | Yes |
Oct 3, 2022
Alloy Therapeutics
|
Series D | $42M | Biopharma | Yes |
Jul 26, 2022
Spotnana Technology
|
Series B | $75M | Business Travel | — |
Jul 13, 2022
Xilis
|
Series A | $19M | Biotechnology | — |